pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Pain · news · pharmadog
← back to Pain
News · Pain
296
stories
20d
FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis
fda press
20d
Vitality Works Inc. Recalls 365 Whole Foods Market Ashwagandha Capsules Sold Nationwide Due to Potential Salmonella Contamination
fda recalls
20d
With Setara, the team behind Actio opens its second act
biopharma dive
21d
Chutes & Ladders—Lilly unifies global markets as 36-year vet Patrik Jonsson retires
fiercebiotech
21d
Ono cans 2 endocannabinoid drug studies after quintuple Phase 2 failure
biospace
22d
Lilly’s retatrutide trounces Novo’s Ozempic in diabetes, weight loss
biospace
23d
Labcorp continues acquisition spree as it buys up Millennium Health
fiercebiotech
24d
A virus that afflicts cows makes the jump to a human
stat
26d
Opinion: STAT readers on Elizabeth Holmes, cancer screening, and more
stat
26d
Opinion: Christina Applegate puts a face on one of the most consequential challenges in neurology
stat
27d
BMS reveals death from septic pneumonia of multiple sclerosis patient in CAR T trial
biospace
27d
Opinion: It took me 13 years to be diagnosed with MS. Christina Applegate’s misdiagnosis doesn’t surprise me
stat
27d
Opinion: New Medicare policies will keep important pain relief from some patients
stat
28d
Protein degrader specialist Lycia prices $318M IPO
biopharma dive
28d
AbbVie’s skin disease drug lessens abscess burden in Phase 3 but falls below expectations
biospace
28d
Moderna, Merck shares fall on eagerly anticipated cancer vaccine results
biopharma dive
28d
STAT+: AbbVie skin disorder drug succeeds in late-stage trial, but results miss market expectations
stat
28d
FDA Launches New Program to Advance Neuroscience Medical Product Development
fda press
28d
AbbVie scratches out phase 3 hidradenitis suppurativa win but falls short of expectations
fiercebiotech
28d
Roivant's TYK2/JAK inhibitor reduces need for steroids in inflammatory eye disease
biospace
29d
Drug prices climb past $250K as US patients balk at the pharmacy
biospace
29d
Disc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headliners
biospace
Oct 20, 26
FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
fda press
Oct 20, 26
Most new drugs are still too costly at launch, ICER says
biopharma dive
Oct 19, 26
Trump orders creation of NIH division, task force on women’s health
stat
Oct 19, 26
Disc’s once-spurned rare disease drug to get a second chance at approval
biopharma dive
Oct 19, 26
As AbbVie’s Crohn’s combo beats Skyrizi in mid-stage test, analysts laud autoimmune vision
biospace
Oct 19, 26
Disc’s rebuffed rare disease drug sets up FDA redo after ‘clean’ Phase 3 sweep
biospace
Oct 19, 26
Disc’s rebuffed rare blood disease drug sets up FDA re-do after ‘clean’ Phase 3 sweep
biospace
Oct 19, 26
Enlivex lays off 60% of employees, scraps preclinical R&D and gives execs ‘substantial’ salary cuts
fiercebiotech
← prev
page 2 of 10
next →